HD-OPM Archive
Topics › Statins

All 25 statin RCTs up to 2016 cut heart attacks and strokes; statins regress soft plaque

Louis Nervegna · Jul 26, 2025 · ♥ 24 reactions · 21 comments · original Facebook post
StatinsPlaque, CAC & CT angiographyHeart attack, stroke & procedures
↻ This is a repost. The main version (highest ranked) is 25 statin trials: about 40% fewer heart attacks and strokes per 75 mg/dL LDL drop · Mar 23, 2025.
AI summary & key facts

Louis explains that calcified plaque comes from soft plaque, and that statins regress soft plaque when LDL is low enough. He shares a graph of 25 statin RCTs, excluding only short or small trials, each reducing MACE.

Calcified plaque doesn’t just appear out of nowhere. It comes from soft plaque. You don’t get calcification unless you first have a lot of soft plaque to start. It is this soft plaque which is dangerous and kills you. The calcified plaque is stable and low risk.

Statins reverse soft plaque if the LDL is pushed low enough. At low enough LDL, they will stop the formation of new soft plaque. Multiple studies have proven this:

↪ Intensive statin reversed atherosclerosis on IVUS in a 2004 Cleveland Clinic-led trial

↪ Meta-analysis: lipid-lowering therapy regresses coronary plaque (Li 2021, SATURN)

↪ Plaque regression: about half at LDL near 80, 90% of regressable plaques below 60

↪ Statin studies on plaque regression, with a link to a longer blog post

If you have a lot of existing soft plaque, then exercise and statins will help to stabilize it by calcifying it. This is one of the reasons why people with heart disease who exercise intensely have much less risk of heart attacks and strokes than people who do not. Statins work just like exercise in this respect.

↪ With the same CAC score, fitter people have much lower heart attack risk over 20-25 years

And this is why over 25 large long-running RCT’s have proven that statins significantly reduce risk of heart attacks, strokes, and cardiovascular mortality— because they prevent and reverse soft plaque at low enough LDL, and because they help stabilize what remains via calcification and other mechanisms.

↪ All 25 statin RCTs to 2016: about 75 mg/dL LDL lowering cut heart attack and stroke 40%

↪ 25 statin RCTs: about 75 mg/dL LDL lowering cut heart attack and stroke roughly 40%

#statinscacHD #cacHD #exerciseHD #reverseHD #exercisecacHD

As of 2016, twenty five different randomized-controlled trials each independently showed that statins reduce major adverse cardiac events (MACE), like heart attacks and strokes.

Here are all 25 of them— summarized on one graph.

There is no cherry picking here. This is every RCT conducted on statins up to 2016– except those lasting less than 6 months or with less than 50 adverse clinical events— only very short or small trials were excluded.

A lowering in LDL level of about 75mg/dL (1.9mmol/L) from the statin reduced the risk of having a heart attack or stroke (MACE) by about 40% on average, as compared to people taking a placebo.

(For example, someone with an LDL of 100mg/dL taking a statin in these trials would have a 40% lower risk of having a heart attack or stroke (MACE) on average than someone with LDL of 175mg/dL taking a placebo.)

To understand how this translates into a large reduction in absolute risk over the long term, see this post:

↪ Statin absolute risk reduction is cumulative: 1-2% in trials, far more over a lifetime

Seven of these clinical trials were primary prevention trials— participants who never had a heart attack or stroke before— as shown on the graph (circles). Notice that the risk reductions for the 7 primary prevention trials (circles) were even larger than the risk reductions for the 18 secondary prevention trials (squares).

Since 2016, even more clinical trials on statins have corroborated this.

This is WHY statins are now the standard of care in cardiology.

Note that 40mg/dL of LDL corresponds to about 1mmol/L.

Reference for this graph:

PaperAssociation Between Lowering LDL C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions A Systematic Review and Meta analysisresearchgate.net

#statinsHD #statinrctsHD #ldlrctsHD #ldlHD #cacHD

No photo description available.
← newer: Vitamin C may reprogram epigenetics in skin cells, a lab finolder: Protein type matters more than amount: processed meat worst, →